Ernährungsstatus und Ernährungstherapie bei HIV-Infizierten

  • B. Lembcke
  • A. Schulte-Bockholt
  • T. Wehrmann
  • M. Ott
  • W. F. Caspary
Conference paper

Zusammenfassung

Die terminale Phase sowie besondere Verlaufsformen („wasting“ oder „slim disease“) der HIV-Infektion sind durch einen progressiven, ungewollten Gewichtsverlust charakterisiert, dessen Pathogenese und dessen Folgen für den weiteren Verlauf der Erkrankung bisher nicht hinreichend geklärt sind.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Brolin RE, Gorman RC, Milgrim LM et al. (1991) Use of nutrition support in patients with Aids: a four-year retrospective review. Nutrition 7: 19–22PubMedGoogle Scholar
  2. 2.
    Cheblowski RT, Grosvenor MB, Bernhard NH et al. (1989) Nutritional status, gastrointestinal dysfunction, and survival in patients with Aids. Am J Gastroenterol 84: 1288–1293Google Scholar
  3. 3.
    Council of State and Territorial Epidemiologists, Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immuno-deficiency syndrom. MMWR 36 (Suppl): 3S - 14SGoogle Scholar
  4. 4.
    Dworkin B, Axelrod F, Pierre N et al. (1989) An analysis of nutrient intake in patients with Aids, Aids-related complex (ARC) and asymptomatic HIV positive controls. Gastroenterology 96: A133Google Scholar
  5. 5.
    Gorbach SL, Knox TA, Roubenoff R (1993) Interactions between nutrition and infection with human immunodeficiency virus. Nutr Rev 51: 226–234PubMedCrossRefGoogle Scholar
  6. 6.
    Grunfeld C, Pang M, Shimizu L et al. (1992) Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 55: 455–460PubMedGoogle Scholar
  7. 7.
    Henry K, Thurn JR, Johnson S (1989) Experience with central venous catheters in patients with Aids. N Engl J Med 320: 1496PubMedGoogle Scholar
  8. 8.
    Hommes MJ, Romijin JA, Godfried MH et al. (1990) Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 39: 1186–1190PubMedCrossRefGoogle Scholar
  9. 9.
    Kotler DP, Tierney AR, Wang J, Pierson RN (1989) Magnitude of body cell mass depletion and timing of death from wasting in Aids. Am J Clin Nutr 50: 444–447PubMedGoogle Scholar
  10. 10.
    Kotler DP, Tierney AR, Altilio D et al. (1989) Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 149: 901–904PubMedCrossRefGoogle Scholar
  11. 11.
    Lähdevirta J, Maury CPJ, Teppo AM et al. (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrom. Am J Med 85: 289–291PubMedCrossRefGoogle Scholar
  12. 12.
    Madara JL, Stafford J (1989) Interferon-y directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83: 724–727PubMedCrossRefGoogle Scholar
  13. 13.
    Ott M, Lembcke B, Fischer H et al. (1993) Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 57: 15–19PubMedGoogle Scholar
  14. 14.
    Ott M, Wegner A, Caspary WF, Lembcke B (1993) Intestinal absorption and malnutrition in patients with the acquired immunodeficiency syndrome (Aids). Z Gastroenterol 31: 661–665PubMedGoogle Scholar
  15. 15.
    Ott M, Fischer H, Polat H et al. (1995) Bioelectrical impedance analysis as a predictor of survival in patients with the human immunodeficiency virus-infection. JAIDS (in press)Google Scholar
  16. 16.
    Raviglione MC, Battan R, Pablos-Mendez A et al. (1989) Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 86: 780–786PubMedCrossRefGoogle Scholar
  17. 17.
    Sherry BA, Gelin J, Fong Y et al. (1989) Anticachectin/tumor necrosis factor-a antibodies attenuate development of cachexia in tumor models. FASEB J 3: 1956–1962PubMedGoogle Scholar
  18. 18.
    Shizgal HM (1990) Validation of the measurement of body composition from whole body bio-electric impedance analysis. Infusiontherapie 17 (Suppl 3): 64–74Google Scholar
  19. 19.
    Singer P, Rothkopf MM, Kvetan V et al. (1991) Risks and benefit of home parenteral nutrition in the acquired immunodeficiency syndrome. JPEN 15: 75–79CrossRefGoogle Scholar
  20. 20.
    Sluys TEMS, van der Ende ME, Swart GR et al. (1993) Body composition in patients with acquired immunodeficiency syndrome: a validation study of bioelectric impedance analysis. JPEN 17: 404–406CrossRefGoogle Scholar
  21. 21.
    Süttmann U, Müller MJ, Ockenga J et al. (1991) Malnutrition and immune dysfunction in patients infected with human immunodeficiency virus. Klin Wochenschr 69: 156–162PubMedCrossRefGoogle Scholar
  22. 22.
    Süttmann U, Selberg O, Müller MJ et al. (1993) Home enteral nutrition in patients with acquired immunodeficiency syndrome. Clin Nutr 12: 287–292PubMedCrossRefGoogle Scholar
  23. 23.
    Weiss PJ, Wallace MR, Olson PE et al. (1993) Changes in the mix of Aids-defining conditions (letter). N Engl J Med 324: 1962CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • B. Lembcke
  • A. Schulte-Bockholt
  • T. Wehrmann
  • M. Ott
  • W. F. Caspary

There are no affiliations available

Personalised recommendations